APOLLO: Patisiran Reduces Polyneuropathy in hATTR Amyloidosis APOLLO: Patisiran Reduces Polyneuropathy in hATTR Amyloidosis

Randomized data from the APOLLO phase 3 study show significant improvement in polyneuropathy with treatment, ' the first time in the amyloid story, ' researchers say.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news